Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT plus PCV in high-risk low-grade gliomas (LGGs). Conference

Bell, Erica Hlavin, McElroy, Joseph P, Fleming, Jessica et al. (2016). Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT plus PCV in high-risk low-grade gliomas (LGGs). . JOURNAL OF CLINICAL ONCOLOGY, 34(15), 10.1200/JCO.2016.34.15_suppl.2017

cited authors

  • Bell, Erica Hlavin; McElroy, Joseph P; Fleming, Jessica; Timmers, Cynthia Dawn; Chakraborty, Arup R; Salavaggione, Andrea L; Shaw, Edward G; Aldape, Kenneth D; Brachman, David; Murtha, Albert D; Won, Minhee; Mehta, Minesh P; Chakravarti, Arnab

authors

date/time interval

  • June 3, 2016 -

publication date

  • May 20, 2016

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • IL, Chicago

Digital Object Identifier (DOI)

Conference

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 34

issue

  • 15